Four questions every SARM COA answers.
The research-active market's failure modes are underdosing, wrong-compound substitution, and prohormone / steroid spiking. HPLC quantifies the dose, MS confirms the molecule, a uniformity check proves every cap matches, and an analog screen catches what the label didn't say.
Published. Per-test.
No quote calls.
Every assay a la carte, every panel bundled. Bulk discount at 5+ samples. Prices below reflect a single-compound submission.
The core SARM COA — is it the compound on the label, and does each unit carry the stated dose. HPLC potency + MS identity on a public COA.
- HPLC-UV potency %
- LC-MS/MS identity
- Label-claim mg per unit
- Public COA + accession #
Adds the purity, uniformity, and adulterant screen a vendor needs to stand behind a lot.
- Identity + Potency
- Purity / related substances
- Content uniformity (RSD)
- Adulterant / analog screen
Adds heavy metals and microbial limits for powders and capsules made from bulk overseas API.
- Everything in Vendor QC
- Heavy metals (ICP-MS, USP <232>)
- Microbial limits (USP <61>)
- Public COA + accession #
The research-active library.
The SARM, SERM, and nootropic market spans a dozen high-demand compounds with distinct label-claim and substitution risks. Here's where the failures cluster.
Research-use only, USP methods, ISO 17025 Aligned, 21 CFR Part 11.
SARMs sit outside the FDA finished-drug pathway; the analytical methods still anchor to USP chromatography and ICH impurity practice. Here's what we map to.
SARMs, many SERMs, and research nootropics are not FDA-approved for human use. A Gold Standard COA verifies identity, potency, and purity for research and manufacturing QC — it is not an endorsement of consumption, a workplace test, or an anti-doping determination.
The compendial chromatography chapter our HPLC potency and purity methods follow for system suitability and resolution.
Reporting, identification, and qualification thresholds for related substances; impurities above 0.5 % get individual MS identification.
ICP-MS heavy-metals limits for powders and capsules made from bulk API, available as the metals add-on.
Raw chromatograms and mass spectra retained per 21 CFR Part 11-style data-integrity principles, available to the client of record on request.
Two things above all — identity (is it actually the compound on the label, by mass spec) and potency (does each unit contain the stated dose, by HPLC). We add purity, content uniformity, and an adulterant screen for undeclared SARMs, prohormones, and steroids. Results go on a public COA.